수행경험
Experience
By Indication
| 적응증 | 비율 |
|---|---|
| Respiratory | 6% |
| Immunology | 9% |
| Oncology | 3% |
| ENT | 6% |
| Ophthalmology | 6% |
| Gastroenterology | 15% |
| Endocrinology | 18% |
| Cardiovascular | 18% |
| Infectious Disease | 3% |
| Nephrology | 3% |
| CNS | 12% |
By Study Phase
| 임상 단계 | 비율 |
|---|---|
| phase1 | 58% |
| phase2 | 9% |
| phase3 | 6% |
| 기타 | 24% |
By Patient Number
| 대상자 수 | 비율 |
|---|---|
| 0~50 | 60% |
| 51~100 | 16% |
| 101~ | 24% |
2024.1Q 기준